[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global and North America Peptide Therapeutics Market Status and Future Forecast 2013-2023

May 2018 | 73 pages | ID: G449294D186EN
99Strategy

US$ 2,500.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
SUMMARY

Key Content of Chapters (Including and can be customized)

Part 1:
Market Overview, Development, and Segment by Type, Application & Region
Part 2:
Global Market by company, Type, Application & Region
Part 3:
North America Market by company, Type, Application & Region
Part 4-6:
Key Regions of North America Market by Type, Application
Part 7:
Company information, Sales, Cost, Margin etc.
Part 8:
Conclusion

Market Segment as follows:

By Region
  • Global (North America, Europe, Asia etc.)
  • North America (United States, Canada, Mexico)
Key Companies
  • Sanofi
  • Teva
  • Novo Nordisk
  • Takeda
  • Eli Lilly
  • AstraZeneca
  • Novartis
  • Shire
  • AbbVie
  • Ipsen
  • Allergan
  • Ferring
  • Merck
  • The Medicines
  • Roche
  • J & J
Market by Type
  • Injection
  • Oral
  • Other
Market by Application
  • Cancer
  • Metabolic Disorders
  • Central Nervous System
  • Others
PART 1 MARKET OVERVIEW

1.1 Market Definition
1.2 Market Development
1.3 By Type
1.4 By Application
1.5 By Region

PART 2 GLOBAL MARKET STATUS AND FUTURE FORECAST

2.1 Global Market by Region
2.2 Global Market by Company
2.3 Global Market by Type
2.4 Global Market by Application
2.5 Global Market by Forecast

PART 3 NORTH AMERICA MARKET STATUS AND FUTURE FORECAST

3.1 North America Market by Region
3.2 North America Market by Company
3.3 North America Market by Type
3.4 North America Market by Application
3.5 North America Market by Forecast

PART 4 UNITED STATES MARKET STATUS AND FUTURE FORECAST

4.1 United States Market by Type
4.2 United States Market by Application
4.3 United States Market by Forecast

PART 5 CANADA MARKET STATUS AND FUTURE FORECAST

5.1 Canada Market by Type
5.2 Canada Market by Application
5.3 Canada Market by Forecast

PART 6 MEXICO MARKET STATUS AND FUTURE FORECAST

6.1 Mexico Market by Type
6.2 Mexico Market by Application
6.3 Mexico Market by Forecast

PART 7 KEY COMPANIES

7.1 Sanofi
7.2 Teva
7.3 Novo Nordisk
7.4 Takeda
7.5 Eli Lilly
7.6 AstraZeneca
7.7 Novartis
7.8 Shire
7.9 AbbVie
7.10 Ipsen
7.11 Allergan
7.12 Ferring
7.13 Merck
7.14 The Medicines
7.15 Roche
7.16 J & J

PART 8 CONCLUSION

LIST OF TABLES

Table Type of Peptide Therapeutics
Table Application of Peptide Therapeutics
Table Global Peptide Therapeutics Market by Region, 2013-2017 (Million USD)
Table Global Peptide Therapeutics Market by Region, 2013-2017 (Volume)
Table Price List by Region, 2013-2017
Table Global Peptide Therapeutics Market by Company, 2013-2017 (Million USD)
Table Global Peptide Therapeutics Market by Company, 2013-2017 (Volume)
Table Price List by Company, 2013-2017
Table Global Peptide Therapeutics Market by Type, 2013-2017 (Million USD)
Table Global Peptide Therapeutics Market by Type, 2013-2017 (Volume)
Table Price List by Type, 2013-2017
Table Global Peptide Therapeutics Market by Application, 2013-2017 (Million USD)
Table Global Peptide Therapeutics Market by Application, 2013-2017 (Volume)
Table Price List by Application, 2013-2017
Table North America Peptide Therapeutics Market by Region, 2013-2017 (Million USD)
Table North America Peptide Therapeutics Market by Region, 2013-2017 (Volume)
Table Price List by Region, 2013-2017
Table North America Peptide Therapeutics Market by Company, 2013-2017 (Million USD)
Table North America Peptide Therapeutics Market by Company, 2013-2017 (Volume)
Table Price List by Company, 2013-2017
Table North America Peptide Therapeutics Market by Type, 2013-2017 (Million USD)
Table North America Peptide Therapeutics Market by Type, 2013-2017 (Volume)
Table Price List by Type, 2013-2017
Table North America Peptide Therapeutics Market by Application, 2013-2017 (Million USD)
Table North America Peptide Therapeutics Market by Application, 2013-2017 (Volume)
Table Price List by Application, 2013-2017
Table United States Peptide Therapeutics Market by Type, 2013-2017 (Million USD)
Table United States Peptide Therapeutics Market by Type, 2013-2017 (Volume)
Table Price List by Type, 2013-2017
Table United States Peptide Therapeutics Market by Application, 2013-2017 (Million USD)
Table United States Peptide Therapeutics Market by Application, 2013-2017 (Volume)
Table Price List by Application, 2013-2017
Table Canada Peptide Therapeutics Market by Type, 2013-2017 (Million USD)
Table Canada Peptide Therapeutics Market by Type, 2013-2017 (Volume)
Table Price List by Type, 2013-2017
Table Canada Peptide Therapeutics Market by Application, 2013-2017 (Million USD)
Table Canada Peptide Therapeutics Market by Application, 2013-2017 (Volume)
Table Price List by Application, 2013-2017
Table Mexico Peptide Therapeutics Market by Type, 2013-2017 (Million USD)
Table Mexico Peptide Therapeutics Market by Type, 2013-2017 (Volume)
Table Price List by Type, 2013-2017
Table Mexico Peptide Therapeutics Market by Application, 2013-2017 (Million USD)
Table Mexico Peptide Therapeutics Market by Application, 2013-2017 (Volume)
Table Price List by Application, 2013-2017
Table Sanofi Information
Table Peptide Therapeutics Sales, Cost, Margin of Sanofi
Table Teva Information
Table Peptide Therapeutics Sales, Cost, Margin of Teva
Table Novo Nordisk Information
Table Peptide Therapeutics Sales, Cost, Margin of Novo Nordisk
Table Takeda Information
Table Peptide Therapeutics Sales, Cost, Margin of Takeda
Table Eli Lilly Information
Table Peptide Therapeutics Sales, Cost, Margin of Eli Lilly
Table AstraZeneca Information
Table Peptide Therapeutics Sales, Cost, Margin of AstraZeneca
Table Novartis Information
Table Peptide Therapeutics Sales, Cost, Margin of Novartis
Table Shire Information
Table Peptide Therapeutics Sales, Cost, Margin of Shire
Table AbbVie Information
Table Peptide Therapeutics Sales, Cost, Margin of AbbVie
Table Ipsen Information
Table Peptide Therapeutics Sales, Cost, Margin of Ipsen
Table Allergan Information
Table Peptide Therapeutics Sales, Cost, Margin of Allergan
Table Ferring Information
Table Peptide Therapeutics Sales, Cost, Margin of Ferring
Table Merck Information
Table Peptide Therapeutics Sales, Cost, Margin of Merck
Table The Medicines Information
Table Peptide Therapeutics Sales, Cost, Margin of The Medicines
Table Roche Information
Table Peptide Therapeutics Sales, Cost, Margin of Roche
Table J & J Information
Table Peptide Therapeutics Sales, Cost, Margin of J & J

LIST OF FIGURES

Figure Global Peptide Therapeutics Market Share by Type in 2018
Figure Global Peptide Therapeutics Market Share by Application in 2018
Figure Global Peptide Therapeutics Market Share by Region in 2018
Figure North America Peptide Therapeutics Market Share by Region in 2018
Figure Global Peptide Therapeutics Market Share by Region in 2017 (Million USD)
Figure Global Peptide Therapeutics Market Share by Region in 2017 (Volume)
Figure Global Peptide Therapeutics Market Share by Company in 2017 (Million USD)
Figure Global Peptide Therapeutics Market Share by Company in 2017 (Volume)
Figure Global Peptide Therapeutics Market Share by Type in 2017 (Million USD)
Figure Global Peptide Therapeutics Market Share by Type in 2017 (Volume)
Figure Global Peptide Therapeutics Market Share by Application in 2017 (Million USD)
Figure Global Peptide Therapeutics Market Share by Application in 2017 (Volume)
Figure Global Peptide Therapeutics Market Forecast, 2018-2023 (Million USD)
Figure Global Peptide Therapeutics Market Forecast, 2018-2023 (Volume)
Figure North America Peptide Therapeutics Market Share by Region in 2017 (Million USD)
Figure North America Peptide Therapeutics Market Share by Region in 2017 (Volume)
Figure North America Peptide Therapeutics Market Share by Company in 2017 (Million USD)
Figure North America Peptide Therapeutics Market Share by Company in 2017 (Volume)
Figure North America Peptide Therapeutics Market Share by Type in 2017 (Million USD)
Figure North America Peptide Therapeutics Market Share by Type in 2017 (Volume)
Figure North America Peptide Therapeutics Market Share by Application in 2017 (Million USD)
Figure North America Peptide Therapeutics Market Share by Application in 2017 (Volume)
Figure North America Peptide Therapeutics Market Forecast, 2018-2023 (Million USD)
Figure North America Peptide Therapeutics Market Forecast, 2018-2023 (Volume)
Figure United States Peptide Therapeutics Market Share by Type in 2017 (Million USD)
Figure United States Peptide Therapeutics Market Share by Type in 2017 (Volume)
Figure United States Peptide Therapeutics Market Share by Application in 2017 (Million USD)
Figure United States Peptide Therapeutics Market Share by Application in 2017 (Volume)
Figure United States Peptide Therapeutics Market Forecast, 2018-2023 (Million USD)
Figure United States Peptide Therapeutics Market Forecast, 2018-2023 (Volume)
Figure Canada Peptide Therapeutics Market Share by Type in 2017 (Million USD)
Figure Canada Peptide Therapeutics Market Share by Type in 2017 (Volume)
Figure Canada Peptide Therapeutics Market Share by Application in 2017 (Million USD)
Figure Canada Peptide Therapeutics Market Share by Application in 2017 (Volume)
Figure Canada Peptide Therapeutics Market Forecast, 2018-2023 (Million USD)
Figure Canada Peptide Therapeutics Market Forecast, 2018-2023 (Volume)
Figure Mexico Peptide Therapeutics Market Share by Type in 2017 (Million USD)
Figure Mexico Peptide Therapeutics Market Share by Type in 2017 (Volume)
Figure Mexico Peptide Therapeutics Market Share by Application in 2017 (Million USD)
Figure Mexico Peptide Therapeutics Market Share by Application in 2017 (Volume)
Figure Mexico Peptide Therapeutics Market Forecast, 2018-2023 (Million USD)
Figure Mexico Peptide Therapeutics Market Forecast, 2018-2023 (Volume)


More Publications